Changes in exhaled breath particles lipid composition following experimental endotoxin challenge Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
Effects of concentrated ambient air particles (CAPs) on markers of airways inflammation in exhaled breath condensate of healthy volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 237s Year: 2004
The concentration of inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel diseases Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases Year: 2010
Inflammatory mediators in exhaled breath condensate, induced sputum and saliva Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004
Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Airway cytokine expression measured by protein array in exhaled breath condensate: correlation with physiological properties in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 444s Year: 2006
Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004
Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
Inflammatory mediators in exhaled breath condensate in young patients with bronchiectases Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge Source: Eur Respir J 2005; 26: Suppl. 49, 228s Year: 2005
Does human exposure to carbon particles and sulphur dioxide produce adverse changes in markers of inflammation in exhaled breath condensate, nasal lavage or serum? Source: Eur Respir J 2004; 24: Suppl. 48, 604s Year: 2004
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: 1011-1017 Year: 2004
Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma Source: Eur Respir J 2002; 20: 1393-1398 Year: 2002
Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC) Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006
Exhaled breath histamine is reduced following methacholine challenge in patients with mild asthma Source: Eur Respir J 2001; 18: Suppl. 33, 165s Year: 2001
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Cross sectional analysis of inflammatory mediators in exhaled breath condensate from COPD patients and healthy smoking controls Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007
Targeted eicosanoid lipidomics of induced sputum as compared to exhaled breath condensate in asthmatics Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
Biomarkers of oxidative stress in exhaled breath condensate following ozone exposure in volunteers Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001